Headline News about AbbVie![]() ![]() ![]() ![]() ![]() ![]() ![]()
What the Options Market Tells Us About AbbVie
November 06, 2024
Via Benzinga
![]() Via Benzinga
![]() ![]() ![]() ![]()
Merck vs. Bristol-Myers: Analyst Views Differ After Q3 Earnings
November 05, 2024
Via MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
![]()
High-Yield AbbVie Gains Momentum: A 20% Upside Is in Sight
November 04, 2024
Via MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
![]() ![]()
Price Over Earnings Overview: AbbVie
November 01, 2024
Via Benzinga
![]() ![]() ![]()
Market Analysis: AbbVie And Competitors In Biotechnology Industry
October 31, 2024
Via Benzinga
![]() ![]()
AbbVie's Options Frenzy: What You Need to Know
October 30, 2024
Via Benzinga
![]() ![]() ![]() ![]()
AbbVie (ABBV) Q3 2024 Earnings Call Transcript
October 30, 2024
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![]() ![]() ![]() ![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|